Rouxjeane Venter
Rouxjeane Venter publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and Infectious Diseases and Tuberculosis.
- World rank
- #2,072,131 of 7,710,434 ranked researchers
- Rank in South Africa
- #8,754 of 29,826
- Works
- 36
- Citations
- 523
- Citations per work
- 14.5
What does Rouxjeane Venter research?
Rouxjeane Venter's work is mostly in Medicine (83%), Immunology and Microbiology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3082.9%
- Medicine3082.9%
- Everything else515.2%
- Life Sciences11.9%
- 1Infectious Diseases33% of their works
- 2Epidemiology30% of their works
- 3Surgery10% of their works
- 4Pulmonary and Respiratory Medicine5% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Immunology2% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Infectious Diseases and Tuberculosis
- Pneumonia and Respiratory Infections
- Diagnosis and treatment of tuberculosis
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV/AIDS oral health manifestations
- Inhalation and Respiratory Drug Delivery
Which keywords describe Rouxjeane Venter's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Mycobacterium tuberculosis, Tuberculosis, Mycobacterium avium, Nontuberculous Mycobacteria and Clinical Practice Guidelines.
- Pulmonary Drug Delivery
- Pneumocystis
- Inhaler Devices
- Diagnostic Challenges
- Abdominal Tuberculosis
- Spinal Epidural Abscess
- HIV
- Clinical Practice Guidelines
- Mycobacterium avium
- Mycobacterium tuberculosis
- Diagnosis
- Epidemiology
- Treatment
- Tuberculosis
- Nontuberculous Mycobacteria
- Antiretroviral Therapy
- Opportunistic Infections
- Tuberculous Meningitis
- Community-Acquired Pneumonia
- Pneumococcal Conjugate Vaccine
- Oral Manifestations
- Pneumonia
- highly active antiretroviral therapy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Epidemiology624 topics
- Diagnosis583 topics
- Treatment583 topics
- Mycobacterium tuberculosis321 topic
- Tuberculosis321 topic
- Mycobacterium avium231 topic
- Nontuberculous Mycobacteria231 topic
- Clinical Practice Guidelines102 topics
- Antiretroviral Therapy92 topics
- HIV62 topics
- Opportunistic Infections62 topics
- Spinal Epidural Abscess61 topic
- Tuberculous Meningitis61 topic
- Abdominal Tuberculosis41 topic
- Community-Acquired Pneumonia41 topic
- Diagnostic Challenges41 topic
- Pneumococcal Conjugate Vaccine41 topic
- Inhaler Devices31 topic
- Oral Manifestations31 topic
- Pneumocystis31 topic
- Pneumonia31 topic
- Pulmonary Drug Delivery31 topic
- highly active antiretroviral therapy31 topic
Where does Rouxjeane Venter work?
Rouxjeane Venter's main affiliation in the publication record is Stellenbosch University, South Africa.
How many publications and citations does Rouxjeane Venter have?
OpenAlex counts 36 works and 523 citations for Rouxjeane Venter, an h-index of 8, ranking #2,072,131 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rouxjeane Venter. Posts are plain text and can be reported.